In a step toward accelerating the production
of new gene therapies, scientists report in ACS Nano that they have developed remote - controlled, needle - like nanospears capable of piercing membrane walls and delivering DNA into selected cells.
«Efficacy
of new gene therapy approach for toxin exposures shown in mouse study.»
Yesterday a team of University of Pennsylvania researchers — led by Dr Pablo Tebas, Professor Carl June, and Dr Bruce Levine — announced the successful conclusion of a clinical trial to evaluate the safety
of a new gene therapy technique for treating HIV.
Not exact matches
Collectively, this
new kind
of startup can help drive down the cost
of gene therapy discovery for patients.
And a third, different kind
of gene therapy from Spark Therapeutics — to treat a rare inherited form
of blindness — is likely to be approved by the end
of 2017, too, making this year a landmark for treatments that manipulate the body's own biological mechanisms in novel
new ways to fight deadly diseases.
«I think this is just the beginning
of a
new era
of gene therapy.»
Risk Versus Reward: The Value
of Cell
Therapy for Patients and Investors Source: Streetwise Reports (4/25/18) The cell therapy space, encompassing disruptive new treatment including stem cell therapy, immunotherapy and gene editing, has begun to mature, with a handful of product approvals and others in late - stage devel
Therapy for Patients and Investors Source: Streetwise Reports (4/25/18) The cell
therapy space, encompassing disruptive new treatment including stem cell therapy, immunotherapy and gene editing, has begun to mature, with a handful of product approvals and others in late - stage devel
therapy space, encompassing disruptive
new treatment including stem cell
therapy, immunotherapy and gene editing, has begun to mature, with a handful of product approvals and others in late - stage devel
therapy, immunotherapy and
gene editing, has begun to mature, with a handful
of product approvals and others in late - stage development.
The cell
therapy space, encompassing disruptive
new treatment including stem cell
therapy, immunotherapy and
gene editing, has begun to mature, with a handful
of product approvals and others in late - stage development.
«The event, the fourth
of its kind, seeks to raise global awareness and create a forum for collaboration around the wide array
of powerful and promising cell
therapies,
gene therapies, and immunotherapies emerging from medical institutions around the world, as well as the impact
new technology will have on humanity and society,» a press release by the Cure Foundation explains (h / t Christian Post).
The principles that have emerged thus far are these: We should seek
new knowledge
of our
genes (and we can say this without deciding whether the Human Genome Initiative is the wisest and most cost - effective way to do so) We should seek
therapies for the genetic disorders that afflict many people.
In a Policy Forum in the
new issue
of Science, Theodore Friedmann, M.D., from the University
of California in San Diego and colleagues from Montreal and Washington, D.C., highlight how
gene therapy and other methods
of genetic modification are poised to complicate international sports competitions like the Olympics, and indeed already have.
But as
new methods
of genetic modification emerge, both the scientific and the sports communities are becoming increasingly aware that
gene therapy — the insertion
of genes into an individual's cells and tissues — will make its way onto the playing field.
Gene therapy delivered to a specific part
of the brain reverses symptoms
of depression in a mouse model
of the disease — potentially laying the groundwork for a
new approach to treating severe cases
of human depression in which drugs are ineffective.
A one - time intravenous infusion
of the high dose
of gene therapy extended the survival
of patients with spinal muscular atrophy type 1 (SMA1) in a Phase 1 clinical trial, according to a study published in the
New England Journal
of Medicine.
«Fibroblast growth factor receptor inhibitors are
new therapies being developed in clinical trials for patients whose cancer cells have genetic alterations in this family
of genes,» says Roychowdhury, a member
of the OSUCCC — James Translational Therapeutics Program.
Tinkering with the
genes inside people has been limited to
gene therapy, where the changes don't get passed to the next generation (see «Is a
new dawn
of widespread
gene therapy on the horizon?
«Steep funding cuts for the federal health agencies are counterproductive at a time when innovative research is moving us closer to identifying solutions for rare diseases,
new prevention strategies to protect Americans from deadly and costly conditions, advances in
gene therapy,
new technologies for understanding the brain, and treatments that harness the ability
of our immune system to fight cancer.»
The
new method may make some types
of gene therapy easier and could be a boon for researchers hoping to control
gene activity in animals, scientists say.
These deletions also may extend to neighboring
genes, an event known as «collateral lethality,» which may create
new options for development
of therapies for several cancers.
Using a
new technique to deliver
gene -
therapy - like intervention directly where it's needed, researchers at Thomas Jefferson University successfully increased or decreased the muscle tone
of the anal sphincter in appropriate animal models.
In what could be the start
of a
new era
of do - it - yourself
gene therapy, the CEO
of a biotech startup last month skipped town to undergo a very public round
of anti-aging
therapy in Latin America, reports MIT Technology Review.
One clinical trial involves the drug CGF166, a one - time
gene therapy, which, if proven successful in humans, could regenerate
new hair cells within the cochlea that can signal the part
of the brain that processes sound.
These annual telethons now help support four institutions: TIGEM, the Telethon Institute
of Genetics and Medicine; HSR - TIGET, the San Raffaele Telethon Institute
of Gene Therapy; Tecnothon, the laboratories for the creation
of new equipment for the disabled; and the Dulbecco Telethon Institute, which provides research facilities for excellent young Italian scientists.
These include the ability to bring
new, innovative products to the market; progress in oncology, such as the approval
of Genentech's drug Avastin for breast cancer and advances in the use
of gene therapy, despite some setbacks; continuing progress in research on stem cells; the emergence
of treatments for previously untreated diseases; and solutions for food and fuel shortages, such as biocrops and biofuels.
The
new method may make some types
of gene therapy easier...
For his part, Collins, who has led NIH since 2009 and been kept on by the Trump administration, pointed to an array
of promising NIH activities, including the development
of new technologies to provide insights into human brain circuitry and function through the Brain Research through Advancing Innovative Neuroethologies (BRAIN initiative) and the use
of the
gene - editing tool CRISPR - Cas9 to correct mutations and clear the way to develop and test a «curative
therapy» for the first molecular disease: sickle cell disease.
Researchers at the 12th International Neuroscience Winter Conference will explore, among other hot topics in neuroscience, the neurobiology
of courtship,
new gene therapy approaches in Parkinson's disease, the role
of sleep in neuropsychiatric disorders and breakthroughs in brain repair.
In a
new study, researchers are taking joint biopsy tissue from patients at the start
of a
new therapy and then six weeks later to see if they can find a predictor
gene sequence that will clearly identify which patients respond to a particular
therapy.
Inhibiting NF - ƘB in microglia in mice slowed disease progression by 47 percent, says Brian Kaspar, MD, a principal investigator in the Center for
Gene Therapy at Nationwide Children's and senior author
of the
new study.
The benefit
of this approach over other
gene therapy techniques is that the
new method can permanently correct the «defect» in a
gene rather than just transiently adding a «functional» one, said Dr. Eric Olson, Director
of the Hamon Center for Regenerative Science and Medicine at UT Southwestern and Chairman
of Molecular Biology.
A case in point: the
new gene therapy for Leber congenital amaurosis, the eye disorder that causes progressive loss
of vision, usually leading to complete blindness by age 40.
But now, the Buck / Berkeley team has identified a
new gene that may accelerate development
of chronic itch
therapies.
It was this
new perspective more than anything else that turned
gene therapy from a simple but failed and frustrated hope into, once again, medicine's next big thing — a stunning spectacle
of hubris, ignominy, and redemption on the scientific stage.
«Single
gene encourages growth
of intestinal stem cells, supporting «niche» cells, and cancer: Finding in mice could lead to
new therapies for damaged organs, cancer.»
So a
new wave
of gene therapy research is turning to nanoparticles to get the job done.
29 GENETICALLY MODIFIED SUPERHUMANS The debate over human germ - line engineering — reworking
genes in the sperm and egg to create inheritable
new traits — sputtered out early in the last decade after
gene therapy had a series
of notable failures.
Despite this
new direction for identifying targets for pharmaceutical interventions against RP, the researchers underscore that
gene therapy still has great potential and possible benefits, and they are actively pursuing efforts with this approach for several forms
of RP.
Gene therapy and its adjuncts may help us trick the body into growing
new tissue to rejuvenate arthritic joints, fix injured hearts, and speed the healing
of wounds.
With the data provided by the FLI researchers, scientists around the world may now set targeted mutations to investigate the relevance
of single
genes for aging, in order to better understand regulating mechanisms and, eventually, develop
new approaches for
therapy or prevention
of aging - related diseases.
«We are encouraged by these promising results and look forward to optimizing the intracranial distribution
of this
new nanoparticle
gene therapy strategy,» says Tyler.
New insights into specific
gene mutations that arise in this often deadly form
of brain cancer have pointed to the potential
of gene therapy, but it's very difficult to effectively deliver toxic or missing
genes to cancer cells in the brain.
Dr Wenxin Wang is trying to uncover
therapies for diseases such as diabetic ulcers and Epidermolysis Bullosa, which causes chronic skin conditions: «We are currently investigating the use
of these
new materials for biomedical applications such as drug /
gene delivery, cross linkable hydrogel materials and skin adhesives.
«The good news is that this finding predicts that patients missing either
gene should be sensitive to
new therapies targeting focal adhesion enzymes, which are currently being tested in early - stage clinical trials,» says Shaw, who is also a member
of the Moores Cancer Center and an adjunct professor at the University
of California, San Diego.
The researchers conclude this technique could eventually lead to
new ways to prepare vast numbers
of cells for the coordinated manufacture
of gene therapies.
«Enhancer RNAs alter
gene expression:
New class
of molecules may be key emerging «enhancer
therapy».»
The Alliance for Cancer
Gene Therapy, the Lance Armstrong Foundation, Leukemia Research Foundation, and the Scleroderma Foundation are just a few examples
of the organizations supporting
new investigator grants.
A
new gene therapy treatment has restored some sight in a handful
of blind patients suffering from Leber's congenital amaurosis, a syndrome in which, because
of a broken or missing
gene called RPE65, retinal photoreceptor cells malfunction and eventually die.
Specifically, the
new results boost knowledge about the effects
of the viral vector used, adeno - associated virus, which has been successfully used in
gene therapy for the eye since 2008.
The
new Salk tool, called CasRx, opens up the vast potential
of RNA and proteins to genetic engineering, giving researchers a powerful way to develop
new gene therapies as well as investigate fundamental biological functions.
Dr. Martinez - Agosto noted, «Looking at the functionality
of these
genes and their effect on the immune response has great potential for accelerating the development
of new targeted
therapies.»